Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets

v3.21.2
Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 28,905,993 $ 28,660,375
Total current assets 28,905,993 28,660,375
Acquired patents, net 13,518 16,227
Total assets 28,919,511 28,676,602
Current liabilities    
Accounts payable & accrued interest 295,845 710,971
Unreimbursed expenses 159,274 59,367
Advance from related party/shareholder 275,154
Total current liabilities 455,119 1,045,492
Total liabilities 455,119 1,045,492
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,993,609 and 12,703,541 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 12,994 12,704
Additional paid-in capital 59,738,222 56,695,359
Accumulated deficit (31,286,824) (29,076,953)
Total stockholders’ equity 28,464,392 27,631,110
Total liabilities and stockholders’ equity $ 28,919,511 $ 28,676,602